Glenn P. Sblendorio
2011 - Medicines
In 2011, Glenn P. Sblendorio earned a total compensation of $1.9M as President and Chief Financial Officer at Medicines, a 99% increase compared to previous year.
Compensation breakdown
| Bonus | $410,549 |
|---|---|
| Option Awards | $690,019 |
| Salary | $501,280 |
| Stock Awards | $314,100 |
| Other | $3,354 |
| Total | $1,919,302 |
Sblendorio received $690K in option awards, accounting for 36% of the total pay in 2011.
Sblendorio also received $410.5K in bonus, $501.3K in salary, $314.1K in stock awards and $3.4K in other compensation.
Rankings
In 2011, Glenn P. Sblendorio's compensation ranked 3,427th out of 10,747 executives tracked by ExecPay. In other words, Sblendorio earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,427 out of 10,747 | 68th |
Division Manufacturing | 1,191 out of 3,960 | 70th |
Major group Chemicals And Allied Products | 232 out of 1,038 | 78th |
Industry group Drugs | 129 out of 786 | 84th |
Industry Pharmaceutical Preparations | 107 out of 571 | 81st |
Source: SEC filing on April 30, 2014.
Sblendorio's colleagues
We found four more compensation records of executives who worked with Glenn P. Sblendorio at Medicines in 2011.